Skip to content

Star Equity Holdings, Inc. - Se (STRRP) Company Overview

Company Analysis

Star Equity Holdings, Inc. - Se STRRP

A comprehensive view of key metrics, scores, and financial health for Star Equity Holdings, Inc. - Se

Overview of Star Equity Holdings, Inc.

STRRP NMS
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics
Star Equity Holdings, Inc. (STRRP), in the Diagnostics & Research industry, last closed at $8.90, about 0.0% overvalued vs fair value, -9.6% 1Y return, ranked 861/1145 in sector.
Metrics Rev Growth 22.9% ROE -11.2% Gross Margin 46.4%
USD 8.90
-0.56%
(Delayed)
• Vol 90d: 23.5%
52-Week Range
Enterprise Value
-
Overall Score
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 94%
Confidence: 88%
Updated: Oct 31
Top Beats

Quick Facts

HQ Old Greenwich, CT
Employees 980
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$172.2M
22.9%%
Gross Profit
$79.9M
13.9%%
Operating Income (GAAP)
-$3.7M
3.2%%
EBITDA
-$1.6M
34.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
46.4%
Fair

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$3.4M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Star Equity Holdings, Inc. - Se's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
47
/100
Developing
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Strong Operating Margin vs Peers Operating margin level is strong vs peers (score 0.68). SG&A discipline is converting gross margin into operating profit efficiently.
  • Conservative Leverage Leverage position is conservative vs peers (score 0.65). Balance sheet flexibility is a strategic asset for serial acquirers.

Key risks

  • Declining FCF Margin FCF trend score is negative (score 0.22). Declining FCF margin warrants scrutiny of capital allocation discipline.
  • Operating Margin Compression Operating margin trend is negative (score 0.25). Sustained compression would reduce the commercial moat.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
50

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 85% Coverage
Trade-Off Triangle Visualization A ternary plot showing STRRP's balance between Growth (36.5%), Profitability (31.6%), and Safety (31.9%). Growth 36% Safety 32% Profitability 32%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

60th percentile vs peers
60
Key Signals
Rev Growth YoY 22.9% 81p Asset Growth YoY 1.15 95p Revenue CAGR 3Y -5.0% 20p
  • Rev Growth YoY in top 20% of peers (22.9%, 81th percentile)
  • Net Debt/EBITDA in top 20% of peers (-7.93, 92th percentile)
  • Conservative leverage compared to industry peers

No significant risks identified for this axis.

Profitability

52th percentile vs peers
52
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

52th percentile vs peers
53
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Star Equity Holdings, Inc. - Se.

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000